Q2 2020 Holdings
Filed 2020-08-14 | 57 holdings | $1.5B | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Ascendis Pharma A S(ASND) | SPONSORED ADR | 04351P101 | $726.9M | 4,914,955 | 48.6% |
| Axsome Therapeutics Inc(AXSM) | COM | 05464T104 | $167.5M | 2,035,132 | 11.2% |
| Adaptimmune Therapeutics PLC(ADAPY) | SPONDS ADR | 00653A107 | $130.7M | 13,052,464 | 8.7% |
| Arvinas Inc(ARVN) | COM | 04335A105 | $123.2M | 3,672,872 | 8.2% |
| Black Diamond Therapeutics Inc(BDTX) | COM | 09203E105 | $109.2M | 2,589,904 | 7.3% |
| Alector Inc(ALEC) | COM | 014442107 | $100.9M | 4,127,348 | 6.7% |
| Ardelyx Inc(ARDX) | COM | 039697107 | $43.3M | 6,260,904 | 2.9% |
| Crinetics Pharmaceuticals Inc(CRNX) | COM | 22663K107 | $40.8M | 2,328,698 | 2.7% |
| Arcutis Biotherapeutics Inc(ARQT) | COM | 03969K108 | $35.2M | 1,165,184 | 2.4% |
| Celldex Therapeutics Inc New(CLDX) | COM NEW | 15117B202 | $15.0M | 1,150,000 | 1.0% |
| Forma Therapeutics Hldgs Inc | SHS | 34633R104 | $419.0K | 9,011,651 | 0.0% |
| Novavax Inc(NVAX) | COM NEW | 670002401 | $396.6K | 4,758,833 | 0.0% |
| Chemocentryx Inc(CCXIEUR) | COM | 16383L106 | $277.7K | 4,826,910 | 0.0% |
| TG Therapeutics Inc(TGTX) | COM | 88322Q108 | $249.1K | 12,788,457 | 0.0% |
| Vaxcyte Inc(PCVX) | COM | 92243G108 | $173.5K | 5,489,181 | 0.0% |
| Adverum Biotechnologies Inc(ADVMCHF) | COM | 00773U108 | $162.9K | 7,801,641 | 0.0% |
| Satsuma Pharmaceuticals Inc | COM | 80405P107 | $134.7K | 4,681,858 | 0.0% |
| Macrogenics Inc(MGNX) | COM | 556099109 | $128.0K | 4,584,652 | 0.0% |
| Phathom Pharmaceuticals Inc(PHAT) | COM | 71722W107 | $125.9K | 3,825,008 | 0.0% |
| Rhythm Pharmaceuticals Inc(RYTM) | COM | 76243J105 | $116.2K | 5,210,088 | 0.0% |
| Kala Pharmaceuticals Inc | COM | 483119103 | $114.3K | 10,874,613 | 0.0% |
| Legend Biotech Corp(LEGN) | SPONSORED ADS | 52490G102 | $105.6K | 2,481,942 | 0.0% |
| Eidos Therapeutics Inc(EIDXGBP) | COM | 28249H104 | $103.1K | 2,162,671 | 0.0% |
| Zogenix Inc | COM NEW | 98978L204 | $99.3K | 3,677,424 | 0.0% |
| Retrophin Inc | COM | 761299106 | $94.6K | 4,635,687 | 0.0% |
| Momenta Pharmaceuticals Inc(MNTA) | COM | 60877T100 | $84.2K | 2,531,445 | 0.0% |
| Wave Life Sciences LTD(WVE) | SHS | Y95308105 | $80.9K | 7,775,207 | 0.0% |
| IGM Biosciences Inc(1K0) | COM | 449585108 | $71.7K | 982,723 | 0.0% |
| Keros Therapeutics Inc(KROS) | COM | 492327101 | $70.3K | 1,875,000 | 0.0% |
| Geron Corp(GERN) | COM | 374163103 | $65.7K | 30,126,299 | 0.0% |
| 89Bio Inc(ETNBGBP) | COM | 282559103 | $63.0K | 3,161,214 | 0.0% |
| Akouos Inc | COM | 00973J101 | $51.3K | 2,281,249 | 0.0% |
| Trillium Therapeutics Inc | COM NEW | 89620X506 | $49.9K | 6,162,694 | 0.0% |
| Orchard Therapeutics PLC | ADS | 68570P101 | $45.7K | 10,403,187 | 0.0% |
| Relmada Therapeutics Inc(RLMD) | COM | 75955J402 | $38.1K | 851,907 | 0.0% |
| Prevail Therapeutics Inc | COM | 74140Y101 | $37.2K | 2,494,691 | 0.0% |
| Stoke Therapeutics Inc(STOK) | COM | 86150R107 | $26.7K | 1,119,963 | 0.0% |
| Scpharmaceuticals Inc(SCPH) | COM | 810648105 | $25.9K | 3,518,998 | 0.0% |
| Avadel Pharmaceuticals PLC | SPONSORED ADR | 05337M104 | $25.3K | 3,126,131 | 0.0% |
| Imara Inc | COM | 45249V107 | $22.9K | 829,348 | 0.0% |
| Ocular Therapeutix Inc(OCUL) | COM | 67576A100 | $22.7K | 2,727,272 | 0.0% |
| Larimar Therapeutics Inc(LRMR) | COM | 517125100 | $19.5K | 1,515,151 | 0.0% |
| Concert Pharmaceuticals Inc(CNCEEUR) | COM | 206022105 | $18.5K | 1,858,474 | 0.0% |
| Verastem Inc | COM | 92337C104 | $15.7K | 9,129,251 | 0.0% |
| Syndax Pharmaceuticals Inc(SNDX) | COM | 87164F105 | $15.2K | 1,023,067 | 0.0% |
| Sutro Biopharma Inc | COM | 869367102 | $14.9K | 1,919,644 | 0.0% |
| Solid Biosciences Inc | COM | 83422E105 | $13.4K | 4,571,164 | 0.0% |
| Repare Therapeutics Inc(RPTX) | COM | 760273102 | $12.7K | 409,000 | 0.0% |
| Lyra Therapeutics Inc(LYRA) | COM | 55234L105 | $9.3K | 815,849 | 0.0% |
| Passage BIO Inc | COM | 702712100 | $8.8K | 322,630 | 0.0% |